Higher electromyographic (EMG) activity levels of corrugator and zygomatic face muscles have been reported to be pretreatment predictors of better clinical outcome in depressed patients. We tested this possibility in 29 drug-free, rigorously diagnosed subjects by measuring low-level EMG activity of corrugator and zygomatic muscles during resting and three imagery states (happy, typical day, sad). All patients had major depressive disorder, endogenous subtype. Good responders had significantly higher pretreatment
Facial expressions
are important barometers of psychomotor state in depressed patients (Greden and Carroll, 1981) . The musculature of the face responds to emotional changes with unique speed and sensitivity (Ekman and Friesen, 1975) , and the facial expressions associated with happiness, sadness, anger, fear, surprise, and disgust are believed to be universal (Darwin, 1872; Ekman et al., 1969) . The corrugator muscles, located on the forehead bilaterally above the bridge of the nose and referred to by Darwin (1872) as the "grief muscles," are considered especially important in displays of sadness, mourning, and grief (Ekman and Friesen, 1972) . Although facial expressions provide visible windows to affective states, their assessment has been subjective and error-prone (Whatmore and Ellis, 1975; Ekman and Friesen, 1975; Greden and Carroll, 198 1) .
In an attempt to develop an objective, quantifiable monitor for facial activity, Schwartz et al. (1975 Schwartz et al. ( , 1976a Schwartz et al. ( , 19766, 1978 Schwartz et al. ( , 1979 Schwartz et al. ( , 1980 studied the use of electromyographic (EMG) measures of low-level facial muscle contractions. He and colleagues placed surface electrodes upon selected muscle regions of the face and recorded EMG activity during self-induced states of affective imagery (e.g.. happy, sad, angry, and "typical day"). A number of muscle regions were studied: (I) corrugator (located bilaterally on the forehead above the bridge of the nose); (2) zygomatic, the "smile muscle," located between the angles of the mouth and cheekbones bilaterally);
and (3) peri-oral muscles such as the depressor anguli oris, depressor labii inferioris, and the mentalis (these muscles produce changes in mouth expressions during affective fluctuations).
Using their EMG approach, Schwartz et al. found diagnostic differences between depressives and normals. Each discrete imagery task produced a distinct EMG profile (Schwartz et al., 1976a (Schwartz et al., , 1976b , and depressed patients differed from nondepressed controls on the basis of their profiles. These results have been replicated by other investigational teams (Teasdale and Bancroft, 1977; Oliveau and Willmuth, 1979; Greden et al., in press ). Perhaps of greater interest than possible diagnostic differences, Schwartz et al. (1978) reported that higher baseline corrugator EMG activity seemed to predict better clinical outcome in their depressed patients. Specifically, they noted that those subjects with the highest initial corrugator levels showed the greatest clinical improvement regardless of treatment selected (amitriptyline or placebo). Laboratory predictors of treatment response are such potentially powerful tools (consider the benefits of bacteria1 culture and sensitivity testing for selecting antibiotics in patients with infectious diseases) that attempts at replication were predictable. Carney et al. (198 1) confirmed that subjects with higher initial corrugator EMG levels had greater changes in depressive symptoms, and suggested that resting zygomatic EMG scores also predicted good outcome.
These studies on prediction of outcome were pilot assessments and subject to expected methodological shortcomings. Specifically, Schwartz and colleagues studied: (1) only outpatients;
(2) the investigations were not conducted under fully "blind" conditions; (3) they required only an unstructured clinical diagnosis of depression and a Zung score above 56 as their inclusion criteria; (4) they studied only the corrugator at rest; (5) they treated patients with relatively low doses of amitriptyline (75-l 50 mg) with no monitoring of plasma levels; and (6) they combined a sample of 5 males and 14 females, later reported by the same group to have different facial EMG responses (Schwartz et al., 1980) . Carney et al. (198 1) studied only female inpatients with significant unipolar depression (Beck depression scores above 20), and studied three left-sided muscle regions; however, 17 or their 21 subjects had been receiving tricyclic antidepressants before study. Both studies also were limited to one followup assessment at 2 weeks, and both emphasized changes in rating scale scores as dependent variables of improvement, thus introducing possible contamination due to Wilder's (1957) law of initial values (subjects with higher levels at one time point will show greater decreases at a second time point). Schwartz et al. (1978) stated: "Until the specific finding for resting corrugator activity is replicated on a larger sample with full-blind conditions, it must be seen as tentative." We agreed, and sought to control for methodological issues mentioned above. After doing so, we replicated and expanded earlier reports that pretreatment EMG activity levels may predict treatment outcome.
Methods

Subjects,
Setting, and Outcome Criteria.
We studied 29 right-handed, female, nondelusional patients. Each was hospitalized in the Clinical Studies Unit (CSU) for Affective Disorders, a 12-bed unit at the University of Michigan Hospital. Each patient was drug-free for IO-14 days before EMG testing. Our evaluation procedure has been described in detail elsewhere (Greden et al., 1980) . In summary, each patient underwent a detailed assessment after drug washout. The assessment included two independent clinical and structured interviews (Schedule for Affective Disorders and Schizophrenia; SADS) (Spitzer and Endicott, 1975 ) and thorough medical screening. Treatments were selected for clinical efficacy. All subjects were treated with imipramine, desipramine, amitriptyline, or maprotoline. Plasma concentrations were documented to be in the therapeutic range (> 180 ng/ ml) for 27 of the 29 patients. Two individuals received maprotoline in an accepted dose range, but had no plasma assays (both were good responders).
All diagnoses and treatment selections were formulated by diagnosticians unaware of EMG results, Raters without knowledge of EMG data completed the 17-item Hamilton Rating Scale for Depression (HRSD) (Hamilton, 1960) on a weekly basis. Go&responders were defined before data analysis as patients with at least a 50% decrease in HRSD scores and a final HRSD score of less than IO (to account for the law of initial values). Poor responders were patients with one or neither of these two criteria.
As shown in Table I , good responders and poor responders did not differ significantly in age, pretreatment severity, diagnostic subtype (unipolar vs. bipolar), postdexamethasone plasma cortisol concentration, or length of treatment. Because of our outcome criteria, the two subgroups showed predictable posttreatment differences at time of hospital discharge in total HRSD scores, Carroll Depression Scale scores, degree of psychomotor retardation, and maximum postdexamethasone plasma cortisol concentrations.
EMG Techniques.
Our EMG procedure, adapted from techniques developed by Schwartz et al., was similar for each subject studied. All patients were asked to complete a questionnaire to determine handedness.
EMGs were conducted between 9 and I1 a.m. to control for possible chronobiological factors. Beckman miniature Ag/ AgCl electrodes were placed bilaterally over the regions of the corrugator and zygomatic muscles, Before electrodes were attached, all skin locations were gently abraded with alcohol pads until a slight redness appeared. Placement procedures were standardized for each muscle region. To distract attention from the study's objectives, we used "dummy" electrodes on both wrists, both forearms over the region of the flexor muscles, and below the left clavicle.
To reduce static charge effects, we placed a single ground connection to the nape of the neck. The low level DC bioelectric potential was amplified, full-wave rectified, and integrated by a Grass Instruments wide band AC preamplifier and integrator (Model 7P3A). This signal was then further amplified by a Grass DC driver amplifier (Model 7DAB). All signals were integrated over a time constant of 500 ms.
Within each session, we stored data collection "runs" for resting (baseline) levels and three imagery states (happy, typical day, and sad). To generate these imagery states, we asked subjects to sit as quietly as possible with eyes closed. We then instructed them: "During this procedure, you will be asked to think about several types of situations. Do the best you can with each of these instructions without actually talking to me. You do not need to tell me what you are thinking. Please try to continue to think about the particular situation until you hear me say to relax."
The specific instructions for the various self-generated stimuli were: "Now 1 want you to think about a particular situation which made you feel [e.g., happy, sad]. While you are thinking about it. please try to reexperience the feeling you had at that time." Instructions for the typical day imagery were further amplified by telling subjects that we wanted them to think sequentially about what they did throughout a typical day until they went to sleep. We log-transformed EMG values before statistical analysis to obtain normality of distribution (Gaddum, 1945) . We then compared EMG values for good and poor responders using a 2 x 4 repeated measures analysis of variance (ANOVA).
The factors used were groups (good and poor responders) and conditions (baseline, happy, typical day, and sad). The x' test or Fisher's Exact Probability Test was used to compare nonparametric variables.
Results
Group means and standard deviations for each muscle region and condition are presented in Table 2 . Fig. I depicts pretreatment mean EMG activity values, and compares good and poor responders. To analyze facial muscle patterns and group differences, we conducted a 2 x 4 repeated measures ANOVA (group as the between factor and condition as the within factor) for the zygomatic and corrugator muscle regions. For the zygomatic region, we found a significant main effect for group (F= 5.09; alf= 1,27;p < 0.05). EMG activity for the good responders was generally higher across conditions than that for the poor responders.
No main effect for condition was found (F= 2.07; df = 3, 81; p > 0.05), indicating similar EMG activity across conditions within each group. No group x condition interaction was found (F = 0.78; df= 3, 81; p > 0.05). We then conducted a repeated measures ANOVA for the corrugator muscle region. In contrast to the zygomatic region, no significant main effect was found for group (F = 0.30; df= 1,27;p > 0.05). A significant main effect for condition was noted (F= 5.99; df= 3,81;p<O.O01).
No group x condition interaction was found (F= 1.02; df=3,8l;p > 0.05). Thus, although no significant group differences were found between good and poor responders in the corrugator region, the condition main effect suggests that both good and poor responders have greater EMG activity for sad imagery than for happy and typical day imagery. Differences across the three imagery states are illustrated in Fig. 1 .
Discussion
These data support prior findings (Schwartz et al., 1978; Carney et al., 1981) that pretreatment facial EMG values may predict treatment outcome in endogenous depressives treated with antidepressants. (Overall et al., 1966; Paykel, 1972; Paykel et al., 1973; Kupfer and Spiker, 1981 (Ekman et al., 1983) .
2. EMG values might covary with other factors that influence outcome, such as chronicity, age, severity, or presence of delusions. In our study, we found little support for age, severity, or delusions accounting for differences, since good responders and poor responders had no pretreatment differences for age or severity, and we excluded delusional subjects. Chronicity will require further study.
3. Patients with increased EMG activity (the good responders) might be more "reactive" to the laboratory situation (Schwartz et al., 1978) and the imagery stimuli. Such increased reactivity could be associated with better outcome. This viewpoint is neither supported by prior studies (Schwartz et al., 1978; Carney et al., 1981) , since significant differences have been found for baseline values, nor by our study, in which zygomatic baseline differences between good and poor responders approached significance (p q 0.07). Nevertheless, the issue requires further evaluation.
4 and/ or treatment differences between good responders and poor responders. Clinically, more intense serial monitoring of "high-risk" subjects (those not predicted to have good outcome) could be conducted during treatment, other etiologies could be sought, and treatment adequacy could be monitored and modified if necessary. The ultimate aim would be to identify more specific or effective treatment approaches for patients who currently respond poorly. Thus, facial EMGs conceivably could be integrated with serial monitoring (Kupfer and Spiker, 1981) to produce improved treatment, the sine qua non of any good laboratory test.
